The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients

Semmelweis University Heart and Vascular Center400 enrolled

Overview

It has been shown retrospectively that participation and even the willingness improves the survival of patients after myocardial infarction or heart failure. We aimed to prospectively analyse the role of participation in cardiology trials on the survival of patients in a high volumen tertiary center.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Myocardial Infarction Chronic Heart Failure

Interventions

Optimal medical therapyDRUG

Optimal medical therapy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hospitalisation due to acute myocardial infarction, and or heart failure * Singed informed consent Exclusion Criteria: * Previous participation in any clinical study * Haemodinamically instable, shock, intubation * Pregnancy, breast feeding

Locations (1)

Semmelweis University, Heart and Vascular Center

Budapest, Hungary

RECRUITING

Outcomes

Primary Outcomes

All-cause mortality

Time frame: 2-years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.